FDA NDI Notifications: We Handle Compliance – Tianzhong Kangyuan Simplifies Market Entry
The 2026 regulatory landscape brings transformative changes for dietary supplement manufacturers. FDA's Human Foods Program has prioritized New Dietary Ingredient (NDI) modernization, with final guidance clarifying safety and identity requirements for ingredients not marketed before October 15, 1994 . For US buyers, navigating these requirements while sourcing Dietary Capsules demands a partner who transforms compliance complexity into competitive advantage.
The NDI Compliance Challenge for Dietary Capsules
Dietary Capsules containing ingredients new to the US market require premarket safety notification at least 75 days before introduction to interstate commerce . Under section 413(a)(2) of the FD&C Act, manufacturers or distributors must submit comprehensive notifications including identity specifications, manufacturing process descriptions, safety evidence, and conditions of use . Failure to submit required NDINs renders nutrition vitamins supplements adulterated under federal law—triggering detention without physical examination and potential warning letters .
FDA's 2026 priorities include developing simplified NDI review processes while maintaining the statutory 75-day timeline . For vitamin food supplement lines and formulations competitive with premium brands like phyto phytophanere, proper NDI status determination protects market access. Ingredients with documented presence in US food supply before 1994 qualify as Old Dietary Ingredients (ODIs) exempt from notification . Our expertise ensures accurate classification for every vitamin e dietary supplement component.
Tianzhong Kangyuan: Your NDI Compliance Partner
Tianzhong Kangyuan Pharmaceutical Group Co.,Ltd maintains comprehensive documentation systems supporting NDI determinations for every Dietary Capsules formulation. Our quality infrastructure includes complete raw material traceability, manufacturing process specifications, and stability data required for FDA submissions . When developing nutrition vitamins supplements with novel ingredients, we coordinate with regulatory specialists to prepare complete NDIN packages meeting 21 C.F.R. § 190.6 requirements .
Service Response: From Determination to Submission
Understanding that NDI compliance requires specialized expertise, our US-dedicated account team coordinates every aspect of the notification process. We conduct thorough gap assessments examining existing data, formulations, and intended marketing claims to identify any areas requiring additional safety evidence . For vitamin food supplement lines requiring NDI notifications, we prepare comprehensive dossiers including:
Complete ingredient identity specifications with physical, chemical, and molecular characterization
Detailed manufacturing process descriptions with process controls
Specification sheets documenting purity, strength, and impurity levels
Safety narratives evaluating history of use or other evidence establishing reasonable expectation of safety
Conditions of use including serving form, serving size, frequency, duration, and target populations
For phyto phytophanere-competitive formulations, our documentation establishes whether botanical ingredients qualify as NDIs based on pre-1994 market presence . When submissions require additional toxicological data, we coordinate preclinical safety studies through qualified laboratories .
The NDI Compliance Advantage
Tianzhong Kangyuan Pharmaceutical Group Co.,Ltd delivers more than Dietary Capsules—we provide regulatory partnership protecting your market access. While FDA's 2026 priorities emphasize NDI modernization and streamlined review processes , our systems ensure your nutrition vitamins supplements enter the US market with complete compliance documentation. From vitamin e dietary supplement lines to innovative vitamin food supplement formulations, we handle NDI compliance so you focus on brand growth.
Partner with us for Dietary Capsules backed by regulatory expertise that transforms FDA requirements from barriers into brand advantages.
